title: Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study.
abstract: The aim of this study was to determine the clinical significance of Streptococcus salivarius isolates recovered from blood cultures and compare them with isolates of Streptococcus bovis biotypes I and II. Seventeen of the 52 (32%) S. salivarius isolates recovered were considered clinically significant, compared with 62 of the 64 (97%) S. bovis isolates (p<0.0001). Bacteremia caused by S. salivarius occurred mostly in patients who showed relevant disruption of the mucous membranes and/or serious underlying diseases. Patients with S. salivarius bacteremia were younger than those with S. bovis bacteremia (57 vs. 67 years; p<0.01). Patients with S. salivarius bacteremia and patients with S. bovis II bacteremia had similar rates of endocarditis, colon tumors, and non-colon cancer. On the other hand, when compared with S. bovis I bacteremia, S. salivarius bacteremia was associated with lower rates of endocarditis (18% vs. 74%, respectively) (p<0.01) and colon tumors (0% vs. 57%, respectively) (p<0.005) and higher rates of non-colon cancer (53% vs. 9.5%, respectively) (p<0.01). Bacteremia caused by S. bovis II had a hepatobiliary origin in 50% of the patients, while, in contrast, that due to S. salivarius or S. bovis I was less frequently associated with a hepatobiliary origin (12% and 5%, respectively) (p<0.00001). The rate of penicillin resistance was 31% among S. salivarius isolates and 0% among S. bovis isolates (p<0.0001). In conclusion, the clinical characteristics of S. salivarius bacteremia and S. bovis II bacteremia are similar, and the isolation of S. salivarius in blood should not be systematically regarded as contamination.
authors.affiliation: Infectious Disease Unit, Hospital Xeral-Calde, C/Severo Ochoa s/n, 27004 Lugo, Spain. juan.corredoira.sanchez@sergas.es
authors.forename: J C
authors.initials: JC
authors.lastname: Corredoira
authors.forename: M P
authors.initials: MP
authors.lastname: Alonso
authors.forename: J F
authors.initials: JF
authors.lastname: García
authors.forename: E
authors.initials: E
authors.lastname: Casariego
authors.forename: A
authors.initials: A
authors.lastname: Coira
authors.forename: A
authors.initials: A
authors.lastname: Rodriguez
authors.forename: J
authors.initials: J
authors.lastname: Pita
authors.forename: C
authors.initials: C
authors.lastname: Louzao
authors.forename: B
authors.initials: B
authors.lastname: Pombo
authors.forename: M J
authors.initials: MJ
authors.lastname: López
authors.forename: J
authors.initials: J
authors.lastname: Varela
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016470:Bacteremia / Q000382:microbiology* / Q000503:physiopathology; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013290:Streptococcal Infections / Q000382:microbiology* / Q000503:physiopathology; D013291:Streptococcus / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D016985:Streptococcus bovis
chemical_list: D000900:Anti-Bacterial Agents